According to Hongyuan Pharmaceutical's announcement, the restricted shares listed and in circulation are shares issued by the company before its initial public offering. The original lockdown period was 36 months. Since the closing price was continuously lower than the issue price for 20 trading days after listing, the lockdown period was automatically extended for 6 months, for a total of 42 months. The number of shares whose sales restrictions have been lifted is 182 million. Since Yin Guoping, Yan Xiaohui, and Liao Shengru are company directors/executives, they transfer no more than 25% of their shares each year during their tenure. The actual number of shares that can be listed and traded this time is 65.2751 million shares. There are no pledges or freezes for shares that have been lifted from sale restrictions.

According to Hongyuan Pharmaceutical's announcement, the restricted shares listed and in circulation are shares issued by the company before its initial public offering. The original lockdown period was 36 months. Since the closing price was continuously lower than the issue price for 20 trading days after listing, the lockdown period was automatically extended for 6 months, for a total of 42 months. The number of shares whose sales restrictions have been lifted is 182 million. Since Yin Guoping, Yan Xiaohui, and Liao Shengru are company directors/executives, they transfer no more than 25% of their shares each year during their tenure. The actual number of shares that can be listed and traded this time is 65.2751 million shares. There are no pledges or freezes for shares that have been lifted from sale restrictions.